Our expertise

With a broad range of experience in developing and marketing ingredients, FrieslandCampina Domo is a key player in the infant nutrition market. As a company, we are continuously looking for ways to grow our expertise, improve our technologies and ensure we remain at the forefront of the industry. Our ingredients and applications are often developed in close collaboration with our customers, providing them with the necessary regulatory, application and analytical support.


Our state-of-the-art Innovation Centre in Wageningen is home to our in-house laboratories, pilot plant and all important research and development work.

Range of HMOs

The first HMO FrieslandCampina DOMO will launch is Aequival® 2’-FL. It is the most prevalent HMO identified in human milk. As there are more than 200 different varieties of HMOs, DOMO is developing a range of HMOs that will be commercially available in the foreseeable future.

Legislation & Safety

Aequival® 2′-FL has a GRAS status and is approved in multiple countries. We assist our customers with registration for 2′-FL and regulatory support for new product development.

Discover more about regulation and safety